- Home
- TBIO
TBIO
Telesis Bio Inc.
as 07-26-2024 4:00pm EST
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 6.4M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 59.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -28.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.02 - $29.34 | Next Earning Date: | 08-08-2024 |
| Revenue: | $24,633,000 | Revenue Growth: | -12.38% |
| Revenue Growth (this year): | -0.63% | Revenue Growth (next year): | 38.06% |
Latest Telesis Bio Inc. News
TBIO Breaking Stock News: Dive into TBIO Ticker-Specific Updates for Smart Investing
MT Newswires
16 days ago
Top Premarket Decliners
Simply Wall St.
2 months ago
With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake
Motley Fool
2 months ago
Better AI Stock: Palantir vs. Snowflake
Motley Fool
2 months ago
Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?
Simply Wall St.
2 months ago
Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)
Motley Fool
2 months ago
BigBear.ai Stock: Buy, Sell, or Hold?
AFP
2 months ago
Indonesia's first Olympic gymnast encourages others to 'dream higher'
Motley Fool
2 months ago
Where Will CrowdStrike Stock Be in 1 Year?
Compare TBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TBIO Telesis Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.